We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Bracco

Offers products, injectors and solutions portfolio for all diagnostic applications from constrast media to medical de... read more Featured Products: More products

Download Mobile App




Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy

By MedImaging International staff writers
Posted on 22 Nov 2024
Print article
Image: Virtual colonoscopy (CT colonography) is an approved option for screening for colorectal cancer in the US (Photo courtesy of Shtutterstock)
Image: Virtual colonoscopy (CT colonography) is an approved option for screening for colorectal cancer in the US (Photo courtesy of Shtutterstock)

Over the last 25 years, virtual colonoscopy has been proven to be a highly accurate, safe, convenient, and cost-effective method of colorectal cancer (CRC) prevention and screening. It can reliably find relevant polyps that are the precursor of CRC while safely confirming the absence of problems in over 90% of those screened. CRC under the age of 50 will increase by 140% by 2030, and only 20% of those aged 45-49 undergo any CRC screening. Now, a new partnership aims to expand the availability of virtual colonoscopy for the early detection of colon and rectal cancer.

Bracco Diagnostics (Milan, Italy), the U.S. subsidiary of Bracco Imaging S.p.A., and ColoWatch (Houston, TX, USA) have entered into a partnership to deliver a turnkey solution for imaging facilities to expand the availability of CRC screening tests using virtual colonoscopy.

"Our partnership with ColoWatch makes implementing the practice of virtual colonoscopy easier for imaging centers, especially those in underserved communities,” said Noelle Heber, Sr. Director of MR, X-Ray, and Device Marketing at Bracco Diagnostics. “With the recent U.S. Centers for Medicare and Medicaid Services recommendation that proposes Medicare reimbursement for CRC screening using virtual colonoscopy, radiology can play an even bigger role in saving lives."

"Colorectal cancer is one of the few cancers that is highly preventable. And yet, there is still a significant population that unfortunately goes unscreened,” added Bikram Bakshi, Co-founder and CEO of ColoWatch. “Widespread implementation of virtual colonoscopies has the potential to save thousands of lives in the United States alone and generate extensive cost-savings for the healthcare system annually. We are proud to partner with Bracco to expand access of this highly important practice and reach more patients who can benefit."

Related Links:
Bracco Diagnostics
ColoWatch

New
Ultrasound Table
Women’s Ultrasound EA Table
3T MRI Scanner
MAGNETOM Cima.X
Silver Member
X-Ray QA Meter
T3 AD Pro
New
Portable HF X-Ray Machine
PORTX

Print article

Channels

Nuclear Medicine

view channel
Image: CD45-PET is a robust, non-invasive tool for imaging inflammation (Photo courtesy of 123RF)

Breakthrough Method Detects Inflammation in Body Using PET Imaging

Inflammation is an immune response that helps protect the body against disease. However, when inflammation becomes chronic and excessive, it can lead to various long-term conditions, including cardiovascular... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.